Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
21 Мб
Скачать
 Infectious Disease and Neurocognition
adversely aect fetal and infant brain development (Shook et al., 2022). Additional long- term data from maternal exposure to SARS- CoV- 2 are needed to better ascer­tain its long- term eects on cognitive and neurological development.
Exposure to prenatal and childhood infections and mental illness in childhood and adulthood
Numerous studies have found associations between exposure to prenatal maternal infections and infections in early childhood and a range of neuropsychiatric dis­orders. Activation of the immune system in pregnant women from infectious dis­eases is associated with the development of autism spectrum disorder, bipolar disorder, and schizophrenia in the children of these women. Complementing these ndings are the results from work in animal models that show that immune activa­tion in the pregnant mothers is associated with behavioral and neurobiological ab­normalities in the ospring (Brown & Meyer, 2018; Estes & McAllister, 2016). Table
24.1 provides a sampling of papers on various infectious diseases and neuropsychi­atric or neurocognitive outcomes.
Illustrating associations between exposure to infectious diseases in early child­hood and the later occurrence of neuropsychiatric illness, a longitudinal study of 71,841 Australian children found that exposure to infectious diseases in early child­hood from ages 1 to 4 years was associated with a shorter number of days to the rst diagnosis of any mental disorder, externalizing mental disorders, and developmental disorders including autism spectrum disorders in children ages 5– 14 years than in children not exposed to infectious diseases (Green et al., 2021). In contrast, prenatal exposure to maternal infection without exposure to early childhood infection was not associated with a shorter number of days to the rst diagnosis of a mental dis­order. Children exposed to both prenatal maternal infection and early childhood in­fection from ages 1 to 4 years had a higher prevalence of childhood mental disorders than children exposed to only early childhood infection (Green et al., 2021).
While evidence associating maternal immune activation with the develop­ment of autism spectrum disorders is not without controversy (Estes & McAllister,
2016), exposure to prenatal and childhood infections has been associated with au­tism spectrum disorders (Sabourin et al., 2019), and some evidence suggests that maternal immune activation can be a risk for the development of autism spectrum disorders in the ospring (Brown & Meyer, 2018). A study from Denmark found that the chemokine monocyte chemotactic protein 1, a type of cytokine involved in neuroinammation, in amniotic uid was associated with autism spectrum dis­orders. Although the study was not designed to identify the cause of the chemo­kine elevation, the authors suggested that gestational exposure to infectious diseases could be a factor (Abdallah et al., 2012). Using Danish health registers, Atladottir et al. (2010) found that while maternal infections in general were not associated with autism spectrum disorders in the ospring, maternal hospitalization in the rst
Infectious Diseases and Development 449
trimester of pregnancy for a viral infection and maternal bacterial infection during the second trimester of pregnancy were associated with autism spectrum disorders in the ospring, although the authors cautioned that more research is necessary to fully characterize associations between maternal infections and the development of autism spectrum disorders in the ospring. Similarly, Zerbo et al. (2015) based on a sample from California found no overall association between gestational maternal infection and autism spectrum disorders in the ospring but did nd an associa­tion between maternal infections diagnosed during a hospitalization, especially with bacterial infections, the most common of which were urinary tract infections, and autism spectrum disorders in the ospring. ey also found that two or more ma­ternal infections were associated with autism spectrum disorders in the ospring. Based on data from a longitudinal Norwegian sample, Hornig et al. (2018) found that maternal fever during the second trimester of pregnancy was associated with autism spectrum disorders in the ospring, with three or more fevers aer 12 weeks of gestation being associated with an even higher risk of autism spectrum disorders in the ospring. Although they did not identify specic types of infections involved with the maternal fevers, the authors concluded that their ndings suggested that maternal fever and associated immune responses were involved in some cases of au­tism spectrum disorders in the ospring. Using Swedish health records, al- Haddad et al. (2019a) found associations between maternal infections during hospitalization including urinary tract infections and autism in the ospring and noted that ma­ternal infection or inammation may account for some cases of autism.
e nature of associations between infectious diseases and neuropsychiatric and cognitive outcomes is likely complex. For example, the herpesvirus cytomegalovirus has been associated with autism spectrum disorders. While there were no dier­ences in cytomegalovirus seroprevalence between people with tuberous sclerosis complex, a genetic disorder highly associated with autism spectrum disorders, and healthy controls, postnatal cytomegalovirus infection appeared to be a risk factor for autism spectrum disorders in children with tuberous sclerosis complex (Yang et al.,
2022). While maternal inuenza infection appears associated with an increased risk of schizophrenia in the ospring, ndings from studies examining associations be­tween maternal inuenza infection and autism spectrum disorders have been mixed, including a large study that found no association between maternal inuenza expo­sure at any time and autism spectrum disorders in the ospring (Zerbo et al., 2017).
Maternal exposure to inuenzas may be associated with an elevated risk of bipolar disorder in the ospring, although the results of studies examining this association have been mixed. In one study, maternal exposure to inuenza was associated with a vefold increase of bipolar disorder with psychotic features in the ospring, al­though it was not associated with ospring bipolar disorder without psychotic fea­tures. e authors speculated that perhaps maternal inuenza infections were not associated with bipolar disorder itself but rather with psychosis (Canetta et al., 2014). Maternal exposure to Toxoplasma gondii, a protozoal parasite, also has been associ- ated with bipolar disorder in the ospring (Brown & Meyer, 2018). Underscoring
 Infectious Disease and Neurocognition
the complex relationship between maternal infection and bipolar disorder in the o­spring were the result of another study using Swedish health records that found no association between maternal infections during hospitalization and bipolar disorder (al- Haddad et al., 2019a), suggesting that other factors might modify the association between maternal infection and bipolar disorder in the ospring, including genetics and inammation (al- Haddad et al., 2019a). However, al- Haddad et al. (2019a) did nd an association between maternal infection including urinary tract infections and depression in the ospring and between maternal infections and later suicide in the ospring.
Childhood infection also might be associated with later depression. In a murine model, exposure to lipopolysaccharide to model infection in pregnant mice was associated with behaviors suggestive of anxiety and depression in male ospring (Enayati et al., 2012). Using data from a large longitudinal cohort, Chaplin et al. (2022) found that the number of common infections during childhood from ages
1.5 to 7.5 years was associated with depression at ages 13 and 14 years but not at ages 18 or 19, with eect sizes increasing with greater infection exposure, ndings suggesting that childhood infections could be associated with depression in ado­lescence. e authors speculated that the lack of associations at ages 18 and 19 years could have been due to participant attrition (Chaplin et al., 2022).
In addition to associations between exposures to prenatal and childhood infec­tions and autism spectrum disorders and aective disorders, infections occurring in childhood and maternal infections during pregnancy have been associated with development of schizophrenia in the ospring (Brown & Derkits, 2010; Debost et al., 2019), although not all the relevant studies have identied associations be­tween prenatal maternal infections and an elevated risk of schizophrenia in the o­spring (al- Haddad et al., 2019a; Blomstrom et al., 2016; Brown & Derkits, 2010). However, other work suggests that infections during childhood do appear to in­crease the risk of later development of schizophrenia, even aer controlling for the eects of low parental socioeconomic status and childhood adversity (Debost et al.,
2019). In addition, mid- trimester maternal inuenza infections have been asso­ciated with an increased risk of schizophrenia in the ospring, and maternal in­fection from a variety of other infectious diseases including herpes simplex virus, rubella, and Toxoplasma gondii also have been associated with an elevated risk of schizophrenia in the ospring. Maternal genital infections also appear to increase the likelihood of schizophrenia in the ospring (Babulas et al., 2006; Brown & Meyer, 2018). Based on data from the Child Health and Development Study, Brown and Patterson (2011) found that the population attributable risk for schizophrenia from maternal exposure to Toxoplasma gondii, inuenza, and maternal genital in- fections was 30 percent, meaning that if the relationships are causal approximately a third of the cases of schizophrenia could be prevented if maternal exposure to Toxoplasma gondii, inuenza, and genital infections was eliminated. Based on data from the Child Health and Developmental study linked with Kaiser Permanente Medical Care Plan registries, Babulas et al. (2006) found that maternal cervicitis,
Infectious Diseases and Development 451
condylomata, endometriosis, gonorrhea, pelvic inammatory disease, vaginitis, sexually transmitted diseases including syphilis during the time from 30 days be­fore the last menstrual period to 30 days aer the last menstrual period were asso­ciated with a ve- times greater risk of schizophrenia and schizophrenia spectrum disorders in the ospring. However, there were no associations with maternal gen­ital and other reproductive infections during the rst, second, and third trimesters and schizophrenia and schizophrenia spectrum disorders. Children of women in­fected with inuenza during the rst half of pregnancy have a threefold increased risk of developing schizophrenia, and children of women infected with inuenza during the rst trimester of pregnancy have a sevenfold increase in schizophrenia, although there were no associations between infection with inuenza in the second half of pregnancy and elevated risk of schizophrenia (Brown & Derkits, 2010). While Blomstrom et al. (2016) using a large Swedish database did not nd an asso­ciation between maternal gestational infection and psychosis in the ospring even aer accounting for whether the maternal infection was viral or bacterial, they did observe that the combination of maternal gestational infection and maternal psy­chosis acted synergistically to increase the risk of the ospring having a psychotic disorder. ey also found evidence that maternal gestational infection increased the likelihood of infections in their ospring, the combination of which also in­creased the risk of psychosis in the ospring. Findings from the same large longitu­dinal birth cohort in England that found associations between childhood infections and depression in adolescence also found an association between the number of common childhood infections between ages 1.5 and 7.5 years and symptoms of psychosis at age 12 years but not at ages 18 and 19 years. Although attrition of study participants could have aected associations at ages 18 and 19 years, these results suggest that exposure to commonly encountered infections during childhood could be associated with psychotic symptoms in adolescence (Chaplin et al., 2022).
While it appears that a variety of maternal infectious diseases are associated with the later occurrence of schizophrenia in the ospring and there might be common mechanisms in how infectious diseases elevate the risk of schizophrenia in the o­spring, there also may be some dierences in the mechanisms by which maternal in­fection elevates the risk of schizophrenia in the ospring between viral and bacterial infections (Brown & Meyer, 2018).
How exposure to infectious diseases in childhood is associated with later mental illness is unclear, although several potential mechanisms exist. Clearly, however, not all maternal infections during pregnancy or all infections during childhood are asso­ciated with neuropsychiatric disorders. In their study of maternal infections during pregnancy and autism spectrum disorders in the ospring, Zerbo et al. (2015) found that 50 percent of all women experienced an infection during pregnancy, a rate far higher than the prevalence of autism spectrum disorders in the general population. Although the individual risk for maternal infection resulting in neuropsychiatric disease in the ospring is likely small, the population eects of maternal infection could be substantial (al- Haddad et al., 2019a).
 Infectious Disease and Neurocognition
While it is possible that the infectious diseases are causing the mental illness, possibly either directly or via inammation, it is also feasible that underlying ge­netic, immunologic (Estes & McAllister, 2016), or socioeconomic factors are asso­ciated with both mental illness and susceptibility to infectious diseases (Green et al.,
2021). Maternal immune activation could interact with susceptibility genes to in­crease the risk of neuropsychiatric disease in the ospring (Brown & Derkits, 2010; Brown & Meyer, 2018). Underlying genetic susceptibilities or socioeconomic vul­nerabilities to both mental illness and infections and infectious disease directly or indirectly possibly through the immune system could aect brain function. In ad­dition, maternal inammatory cytokines released in response to infection can pass through the placental and fetal blood– brain barrier and aect prenatal brain devel­opment (Brown & Patterson, 2011). In a study of maternal inammatory markers and behavior in the ospring, elevated maternal interleukin 8 in the rst trimester of pregnancy was associated with externalizing symptoms (e.g., impulsivity, aggres­sion, acting out, antisocial behavior) in children at ages 9– 11 years, and elevated maternal interleukin- 1 receptor antagonist in the second trimester was associated with internalizing symptoms (e.g., anxiousness, somatization, withdrawal) in girls at ages 9– 11 years. Contextualizing these ndings, the authors note that childhood internalizing and externalizing symptoms are associated with a range of later psy­chopathology (Mac Giollabhui et al., 2019). Findings from animal models show that maternal immune activation can interact with genetic variants to aect beha­vior (Brown & Meyer, 2018). Oxidative stress from infection also could be involved (Waldorf & McAdams, 2013).
A variety of factors likely contributes to how maternal infection can lead to ad­verse neuropsychiatric outcomes in the ospring. e type of infectious disease, its timing during fetal development, maternal and fetal inammatory responses, ma­ternal and fetal genetics, and interactions with other environmental factors, as well as many other factors (al- Haddad et al., 2019a) including direct neuronal injury from an infectious pathogen, placental inammation from infection, disruption of neurotransmitters from infection, and microglial and astrocyte activation as a result in infection (al- Haddad et al., 2019b) can aect fetal brain development and require additional research to better characterize their roles in modifying associations be­tween maternal infection and inammation and neurocognitive and neuropsychi­atric outcomes in the ospring.
Animal models of ospring of mothers exposed to infectious diseases have shown changes in brain function that are highly relevant to pathophysiological ndings as­sociated with schizophrenia in humans (Brown & Derkits, 2010). According to nd­ings from animal models, a two- hit model for some infectious diseases also could be involved in how maternal infectious diseases elevate the risk for psychopathology in the ospring, wherein maternal immune activation from an infectious disease is the rst hit followed by later stress or biological insult, which is the second hit (Brown & Meyer, 2018; Estes & McAllister, 2016), a mechanism that appears relevant to hu­mans (Brown & Meyer, 2018) and that would involve not only infectious diseases
Infectious Diseases and Development 453
but that could include a range psychosocial stresses such as neglect and exposure to poverty during development. While pointing out that most maternal infections do not result in schizophrenia or autism spectrum disorders in the ospring, Estes and McAllister (2016) argue that maternal immune activation from a variety of sources including infectious diseases could make the brain more susceptible to other devel­opmental insults to result in a range of brain disorders. is gateway eect of ma­ternal and possibly childhood infections leading to neuropsychiatric disease in adult ospring could be an important factor driving the incidence of neuropsychiatric disease.
Infections associated with poverty that can aect brain development and influence cognitive and neuropsychiatric outcome
Although infectious diseases can aect people at all socioeconomic levels, people including children living in poverty are at increased risk for exposure to a variety of infectious diseases, increasing the likelihood of their exposure to infectious diseases that have been associated with abnormal brain and child development (Waldorf & McAdams, 2013). Although data are limited, children living in low- and middle­income countries are at higher risk for having disorders of neurodevelopment than are children from regions with higher incomes, a relationship to which exposures to infectious diseases likely contributes (Krebs et al., 2017). Risk factors for many of the parasites that that can have brain involvement include poverty and living in tropical areas (Finsterer & Auer, 2013). Among the diseases disproportionately af­fecting people living in poverty are the neglected tropical diseases, a group of infec­tious diseases estimated to aect approximately 1 billion people worldwide (Hotez,
2014). While disproportionately aecting people living in poverty including many in subtropical regions, the neglected tropical diseases are not necessarily restricted to tropical regions but can aect people living in temperate regions. In this regard, the neglected parasitic infectious diseases Chagas disease, toxoplasmosis, toxocariasis, and cysticercosis, can aect people living in the southern United States, where poor sanitation and environmental contamination are thought to be the main drivers of exposure to infectious diseases (Hotez, 2014). An array of other parasites that are associated with low- income regions, poverty, and tropical areas also can aect the brain. e list of these parasites is long but includes cestodes, nematodes, tremat­odes, and protozoa. In addition to their associations with poverty, many of these infectious diseases have been associated with adverse cognitive or neuropsychiatric outcomes (Finsterer & Auer, 2013; Hotez, 2014).
Chagas disease or American trypanosomiasis is caused by the protozoan parasite Trypanosomiasis cruzi. Associated with cardiomyopathy and a variety of other health problems (Hotez, 2014), Chagas disease has also been associated with adverse neu­ropsychiatric and cognitive outcomes (Finsterer & Auer, 2013). Another protozoal
 Infectious Disease and Neurocognition
disease, toxoplasmosis, caused by the protozoal parasite Toxoplasma gondii, has been associated with schizophrenia, bipolar, disorder, suicide attempts (Hotez, 2014), ep­ilepsy, obsessive– compulsive disorder, decreased cognitive function, and changes in brain volume (Erickson et al., 2021; Flegr et al., 2014; Gale et al., 2020; Mendy et al., 2015; Palmer, 2007). Caused by Toxocara canis or Toxocara cati from eggs in con- taminated soil, toxocariasis is a helminthic parasite (Hotez, 2014) more likely to in­fect people in areas with a low human development index (Rostami et al., 2019) and that also has been associated with decreased cognitive function in children (Walsh & Haseeb, 2012), middle- aged adults, and older adults (Gale & Hedges, 2020). e cause of cysticercosis is Taenia solium, the pig tapeworm. Human can acquire cysticercosis when the parasite forms cysts in brain tissue, which can result in epi­lepsy and other neurological diseases (Garcia et al., 2020). Another example of an in­fectious disease associated with both socioeconomic factors and brain development is cytomegalovirus. Cytomegalovirus is an infectious disease that while occurring across all socioeconomic levels is associated with socioeconomic factors such as crowded living conditions (Adler & Reddehase, 2019). Cytomegalovirus is also as­sociated with cognitive delay (Elliott, 2011) and with autism spectrum disorders in people with tuberous sclerosis (Yang et al., 2022). Infecting a high percentage of the world’s population, the bacterium Helicobacter pylori, too, is associated with poverty, an association that could strengthen with climate change (Khalifa et al., 2010).
An emerging infectious disease threat that has the potential to adversely aect cognitive and brain function in vulnerable children (Otto et al., 2019) as well as in at- risk adults is the increasing incidence of fungal infections including among many others Cryptococcus neoformans and Candida auris, both of which can in­vade the central nervous system (World Health Organization, 2022). While limited data about persistent cognitive and neuropsychiatric eects from brain fungal in­fections are available, the increasing incidence and geographical range of invasive fungal infections, part of which could be related to climate change (World Health Organization, 2022), requires further research into how fungal infections aect childhood and brain development.
Implications for public health
Associations between maternal and childhood infections and the later occurrence of neuropsychiatric disease in the ospring are highly relevant for public health policies and practice. Prevention is paramount (al- Haddad et al., 2019b). In many cases, however, limited overall awareness of the eects of infectious diseases on cog­nitive, neurological, and psychiatric health can impede eorts to prevent exposure to infectious diseases that can aect brain development and cognition (Hotez, 2014). Many maternal infections are in principle treatable (Brown & Derkits, 2010; Brown & Patterson, 2011) or preventable (al- Haddad et al., 2019a) or potentially prevent­able via vaccines, surveillance, treatment of maternal infections (Babulas et al., 2006;
Infectious Diseases and Development 455
Brown & Patterson, 2011), vector control (Wheeler et al., 2020), and other public health measures such as improved sanitation such as, for example, with preventing Toxoplasma gondii (Brown & Derkits, 2010; Brown & Patterson, 2011) and meas­ures designed to decrease sexually transmitted diseases (Brown & Meyer, 2018). Particularly in the case of maternal vaccination, additional research evaluating the risks and benets of maternal vaccination on a variety of maternal and child out­comes including schizophrenia (Brown & Patterson, 2011) and other neuropsychi­atric and cognitive outcomes is needed. Additional research about how maternal antibiotic treatment aects infectious and inammatory outcomes in a fetal brain is required (al- Haddad et al., 2019b).
Conclusion
Maternal and childhood infection likely accounts for some of the incidence and prevalence of neuropsychiatric diseases (al- Haddad et al., 2019b). Prenatal and childhood exposure to some infectious diseases such as inuenza, Toxoplasma gondii, and herpesvirus 2 (Brown & Derkits, 2010) appears to alter fetal and child brain development as shown by associations between some childhood infections and later occurrence of schizophrenia and psychosis and between some maternal infec­tions and the subsequent development of neuropsychiatric disease in the ospring. Maternal gestational infections and inammation, therefore, likely contribute to the overall burden of neuropsychiatric disease and suggest fetal origins of some neuro­psychiatric disease (al- Haddad et al., 2019b). Additional research further exploring the eects of gestational infections, and infections acquired early in life, and inam­mation on brain development and neuropsychiatric diseases including cognitive dysfunction is necessary, keeping in mind the caveat that some fetal brain injuries associated with maternal infection and inammation might not become apparent for many years aer birth (al- Haddad et al., 2019a). Because many infectious dis­eases are potentially preventable or treatable, in principle it is possible to prevent some cases of psychosis and schizophrenia through public health measures to im­prove sanitation, vaccination, and treatment. In fact, targeting the maternal infec­tious diseases that have been associated with schizophrenia in the ospring would possibly substantially decrease the incidence of schizophrenia in part because the maternal infectious diseases associated with ospring schizophrenia are common (Brown & Patterson, 2011). Similarly, preventing maternal and childhood infectious diseases associated with neurocognitive dysfunction could reduce the substantial burden of atypical brain development and cognitive impairment.
Many of the infectious diseases associated with abnormal child and brain devel­opment preferentially aect children and adults in impoverished regions and in low- and middle- income nations where public health and prenatal and pediatric re­sources are limited, resulting in dierential exposure to infectious diseases associ­ated with abnormal child and brain development, adding to a range of other adverse
 Infectious Disease and Neurocognition
eects on developing brain in these already vulnerable populations. As Paul Farmer observed, “one nds little evidence that the non- poor ever faced the same risks as the poor— whether we’re speaking of risk of infection or of poor outcomes once in­fected” (Farmer, 2020, pp. 298– 299). Research involving the eects of public health measures including the prevention and treatment of infectious diseases including maternal infections on the overall burden of neurocognitive and neuropsychiatric diseases in impoverished and low- income regions is sorely needed.
Maternal infectious diseases and inammation appear to contribute to neuropsy­chiatric disease in the ospring and to the overall burden of neuropsychiatric and neurocognitive disease. Treatment and prevention of maternal infectious diseases provide potentially eective methods of reducing the overall burden of neuropsy­chiatric and neurocognitive disease.
References
ABDALLAH, M. W., LARSEN, N., GROVE, J., NORGAARD- PEDERSEN, B., THORSEN, P.,
MORTENSEN, E. L. & HOUGAARD, D. M. 2012. Amniotic uid chemokines and autism spectrum
disorders: An exploratory study utilizing a Danish historic birth cohort. Brain Behav Immuni, 26,
170– 176. ADLER, S. P. & REDDEHASE, M. J. 2019. Pediatric roots of cytomegalovirus recurrence and memory
ination in the elderly. Med Microbiol Immunol, 208, 323– 328. AL- HADDAD, B. J. S., JACOBSSON, B., CHABRA, S., MODZELEWSKA, D., OLSON, E. M.,
BERNIER, R., ENQUOBAHRIE, D. A., HAGBERG, H., OSTLING, S., RAJAGOPAL, L., WALDORF,
K. M. A. & SENGPIEL, V. 2019a. Long- term risk of neuropsychiatric disease aer exposure to infec-
tion in utero. JAMA Psychiatry, 76, 594– 602. AL- HADDAD, B. J. S., OLER, E., ARMISTEAD, B., ELSAYED, N. A., WEINBERGER, D. R., BERNIER,
R., BURD, I., KAPUR, R., JACOBSSON, B., WANG, C. H., MYSOREKAR, I., RAJAGOPAL, L. &
WALDORF, K. M. A. 2019b. e fetal origins of mental illness. Am J Obstetr Gynecol, 221, 549– 562. ATLADOTTIR, H. O., THORSEN, P., OSTERGAARD, L., SCHENDEL, D. E., LEMCKE, S.,
ABDALLAH, M. & PARNER, E. T. 2010. Maternal infection requiring hospitalization during preg-
nancy and autism spectrum disorders. J Autism Dev Disord, 40, 1423– 1430. ATWOLI, L., BAQUI, A. H., BENFIELD, T., BOSURGI, R., GODLEE, F., HANCOCKS, S., HORTON,
R., LAYBOURN- LANGTON, L., MONTEIRO, C. A., NORMAN, I., PATRICK, K., PRAITIES, N.,
RIKKERT, M. G. M. O., RUBIN, E. J., SAHNI, P., SMITH, R., TALLEY, N., TURALE, S. & VAZQUEZ,
D. 2021. Call for emergency action to limit global temperature increases, restore biodiversity, and
protect health: Wealthy nations must do much more, much faster. Neurology, 97, 658– 660. BABULAS, V., FACTOR- LITVAK, P., GOETZ, R., SCHAEFER, C. A. & BROWN, A. S. 2006. Prenatal
exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry,
163, 927– 929. BAUMAN, M. D., IOSIF, A. M., ASHWOOD, P., BRAUNSCHWEIG, D., LEE, A., SCHUMANN,
C. M., VAN DE WATER, J. & AMARAL, D. G. 2013. Maternal antibodies from mothers of chil-
dren with autism alter brain growth and social behavior development in the rhesus monkey. Transl
Psychiatry, 3, e278. BESNIER, E., THOMSON, K., STONKUTE, D., MOHAMMAD, T., AKHTER, N., TODD, A., JENSEN,
M. R., KILVIK, A. & BAMBRA, C. 2019. Which public health interventions are eective in reducing
morbidity, mortality and health inequalities from infectious diseases amongst children in low- income
and middle- income countries (LMICs): Protocol for an umbrella review. Bmj Open, 9, e032981. BLOMSTROM, A., KARLSSON, H., GARDNER, R., JORGENSEN, L., MAGNUSSON, C. &
DALMAN, C. 2016. Associations between maternal infection during pregnancy, childhood
Infectious Diseases and Development 457
infections, and the risk of subsequent psychotic disorder— A Swedish cohort study of nearly 2 mil­lion individuals. Schizophr Bull, 42, 125– 133.
BRANSFIELD, R. C., WULFMAN, J. S., HARVEY, W. T. & USMAN, A. I. 2008. e association be-
tween tick- borne infections, Lyme borreliosis and autism spectrum disorders. Med Hypotheses, 70, 967– 974.
BROWN, A. S. & DERKITS, E. J. 2010. Prenatal infection and schizophrenia: A review of epidemio-
logic and translational studies. Am J Psychiatry, 167, 261– 280.
BROWN, A. S. & MEYER, U. 2018. Maternal immune activation and neuropsychiatric illness: A trans-
lational research perspective. Am J Psychiatry, 175, 1073– 1083.
BROWN, A. S. & PATTERSON, P. H. 2011. Maternal infection and schizophrenia: Implications for
prevention. Schizophr Bull, 37, 284– 290.
BULKA, C. M., AVULA, V. & FRY, R. C. 2021. Associations of exposure to peruoroalkyl substances
individually and in mixtures with persistent infections: Recent ndings from NHANES 1999– 2016. Environ Pollut, 275, 116619.
CANETTA, S. E., BAO, Y. Y., CO, M. D. T., ENNIS, F. A., CRUZ, J., TERAJIMA, M., SHEN, L.,
KELLENDONK, C., SCHAEFER, C. A. & BROWN, A. S. 2014. Serological documentation of ma­ternal inuenza exposure and bipolar disorder in adult ospring. Am J Psychiatry, 171, 557– 563.
CARLSON, C. J., ALBERY, G. F., MEROW, C., TRISOS, C. H., ZIPFEL, C. M., ESKEW, E. A., OLIVAL,
K. J., ROSS, N. & BANSAL, S. 2022. Climate change increases cross- species viral transmission risk. Nature, 607, 555– 562.
CAROD- ARTAL, F. J., WICHMANN, O., FARRAR, J. & GASCON, J. 2013. Neurological complica-
tions of dengue virus infection. Lancet Neurol, 12, 906– 919.
CHANDNA, J., LIU, W. H., DANGOR, Z., LEAHY, S., SRIDHAR, S., JOHN, H. B., MUCASSE, H.,
BASSAT, Q., BARDAJI, A., ABUBAKAR, A., NASAMBU, C., NEWTON, C. R., SÁNCHEZ YANOTTI, C., LIBSTER, R., MILNER, K., PAUL, P., LAWN, J. E. & GBS LOW AND MIDDLE INCOME COLLABORATIVE GROUP FOR LONG- TERM OUTCOMES GROUP. 2022. Emotional and behavioral outcomes in childhood for survivors of invasive group B Streptococcus disease in infancy: Findings from 5 low- and middle- income countries. Clin Infect Dis, 74 Suppl 1, S35– S43.
CHAPLIN, A. B., JONES, P. B. & KHANDAKER, G. M. 2022. Association between common early-
childhood infection and subsequent depressive symptoms and psychotic experiences in adoles­cence: A population- based longitudinal birth cohort study. Psychol Med, 52, 2166– 2176.
DEBOST, J. C., LARSEN, J. T., MUNK- OLSEN, T., MORTENSEN, P. B., AGERBO, E. & PETERSEN, L.
V. 2019. Childhood infections and schizophrenia: e impact of parental SES and mental illness, and childhood adversities. Brain Behav Immun, 81, 341– 347.
DO VALLE, D. A., SANTOS, M. L. S. F., GIAMBERARDINO, H. I. G., RABONI, S. M. & SCOLA, R. H.
2020. Acute childhood viral encephalitis in southern Brazil. Pediatric Infect Dis J, 39, 894– 898.
EDLOW, A. G., CASTRO, V. M., SHOOK, L. L., KAIMAL, A. J. & PERLIS, R. H. 2022.
Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS- CoV- 2 during pregnancy. JAMA Netw Open, 5, e2215787.
ELLIOTT, S. P. 2011. Congenital cytomegalovirus infection: An overview. Infect Disord Drug Targets,
11, 432– 436.
ENAYATI, M., SOLATI, J., HOSSEINI, M. H., SHAHI, H. R., SAKI, G. & SALARI, A. A. 2012. Maternal
infection during late pregnancy increases anxiety- and depression- like behaviors with increasing age in male ospring. Brain Res Bull, 87, 295– 302.
ERICKSON, L. D., BROWN, B. L., GALE, S. D. & HEDGES, D. W. 2021. Association between
Toxoplasma gondii seropositivity and serointensity and brain volume in adults: A cross- sectional study. PLoS One, 16, e0245994.
ESTES, M. L. & MCALLISTER, A. K. 2016. Maternal immune activation: Implications for neuropsy-
chiatric disorders. Science, 353, 772– 777.
FARMER, P. 2020. Fevers, Feuds, and Diamonds: Ebola and the Ravages of History. New York: Farrar,
Straus and Giroux.
FINSTERER, J. & AUER, H. 2013. Parasitoses of the human central nervous system. J Helminthol, 87,
257– 270.